Death possibly associated with interferon use in a patient with chronic hepatitis.
Kendirli
Tanil
T
Kismet
Erol
E
Demirkaya
Erkan
E
Aydin
Halil Ibrahim
HI
Kesik
Vural
V
Köseoğlu
Vedat
V
D000707:Anaphylaxis / Q000139:chemically induced*; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002675:Child, Preschool; D017809:Fatal Outcome; D005260:Female; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins